Voya Investment Management LLC Beam Therapeutics Inc. Transaction History

Voya Investment Management LLC

  • $78.9 Billion
  • Q4 2024

A detailed history of Voya Investment Management LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 23,015 shares of BEAM stock, worth $591,255. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,015
Previous 24,743 6.98%
Holding current value
$591,255
Previous $606,000 5.94%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$21.55 - $30.35 $37,238 - $52,444
-1,728 Reduced 6.98%
23,015 $570,000
Q3 2024

Feb 07, 2025
SELL
$22.57 - $33.14 $438,535 - $643,910
-19,430 Reduced 43.99%
24,743 $606,000
Q3 2024

Nov 14, 2024
SELL
$22.57 - $33.14 $438,535 - $643,910
-19,430 Reduced 43.99%
24,743 $606,000
Q2 2024

Feb 07, 2025
BUY
$21.22 - $32.66 $160,062 - $246,354
7,543 Added 20.59%
44,173 $1.03 Million
Q2 2024

Dec 03, 2024
BUY
$21.22 - $32.66 $412,304 - $634,583
19,430 Added 78.53%
44,173 $1.03 Million
Q2 2024

Aug 14, 2024
BUY
$21.22 - $32.66 $160,062 - $246,354
7,543 Added 20.59%
44,173 $1.03 Million
Q1 2024

Feb 07, 2025
BUY
$23.46 - $45.07 $278,869 - $535,747
11,887 Added 48.04%
36,630 $1.21 Million
Q1 2024

Dec 06, 2024
BUY
$23.46 - $45.07 $278,869 - $535,747
11,887 Added 48.04%
36,630 $1.21 Million
Q1 2024

May 15, 2024
SELL
$23.46 - $45.07 $109,722 - $210,792
-4,677 Reduced 11.32%
36,630 $1.21 Million
Q4 2023

Feb 07, 2025
BUY
$17.69 - $30.76 $16,646 - $28,945
941 Added 2.33%
41,307 $1.12 Million
Q4 2023

Feb 14, 2024
BUY
$17.69 - $30.76 $16,646 - $28,945
941 Added 2.33%
41,307 $1.12 Million
Q3 2023

Feb 07, 2025
BUY
$23.01 - $32.46 $17,280 - $24,377
751 Added 1.9%
40,366 $970,000
Q3 2023

Nov 14, 2023
BUY
$23.01 - $32.46 $17,280 - $24,377
751 Added 1.9%
40,366 $970,000
Q2 2023

Feb 07, 2025
SELL
$29.32 - $35.99 $1.56 Million - $1.92 Million
-53,278 Reduced 57.35%
39,615 $1.26 Million
Q2 2023

Aug 14, 2023
SELL
$29.32 - $35.99 $1.43 Million - $1.75 Million
-48,737 Reduced 55.16%
39,615 $1.26 Million
Q1 2023

Feb 07, 2025
BUY
$30.15 - $48.79 $2.05 Million - $3.33 Million
68,150 Added 275.43%
92,893 $2.84 Million
Q1 2023

May 15, 2023
SELL
$30.15 - $48.79 $2,713 - $4,391
-90 Reduced 0.1%
88,352 $2.71 Million
Q4 2022

Feb 07, 2025
BUY
$36.73 - $51.6 $22,809 - $32,043
621 Added 0.67%
92,983 $3.64 Million
Q4 2022

Feb 14, 2023
BUY
$36.73 - $51.6 $25,637 - $36,016
698 Added 0.8%
88,442 $3.46 Million
Q3 2022

Feb 07, 2025
BUY
$39.79 - $70.31 $2.69 Million - $4.75 Million
67,619 Added 273.29%
92,362 $4.4 Million
Q3 2022

Mar 03, 2023
SELL
$39.79 - $70.31 $27,773 - $49,076
-698 Reduced 0.79%
87,744 $4.18 Million
Q3 2022

Nov 14, 2022
BUY
$39.79 - $70.31 $528,610 - $934,068
13,285 Added 17.84%
87,744 $4.18 Million
Q2 2022

Aug 15, 2022
BUY
$29.86 - $62.36 $424,459 - $886,447
14,215 Added 23.6%
74,459 $2.88 Million
Q1 2022

May 16, 2022
SELL
$53.73 - $82.16 $128,575 - $196,608
-2,393 Reduced 3.82%
60,244 $3.45 Million
Q4 2021

Feb 14, 2022
SELL
$68.02 - $99.06 $5.85 Million - $8.52 Million
-86,015 Reduced 57.86%
62,637 $4.99 Million
Q3 2021

Nov 15, 2021
BUY
$84.37 - $133.6 $11 Million - $17.4 Million
130,168 Added 704.22%
148,652 $12.9 Million
Q2 2021

Aug 16, 2021
BUY
$64.12 - $128.71 $64,376 - $129,224
1,004 Added 5.74%
18,484 $2.38 Million
Q1 2021

May 17, 2021
BUY
$71.28 - $120.75 $34,855 - $59,046
489 Added 2.88%
17,480 $1.4 Million
Q4 2020

Feb 16, 2021
BUY
$22.24 - $95.63 $119,339 - $513,150
5,366 Added 46.16%
16,991 $1.39 Million
Q3 2020

Nov 16, 2020
BUY
$19.0 - $30.57 $220,875 - $355,376
11,625 New
11,625 $286,000

Others Institutions Holding BEAM

# of Institutions
253
Shares Held
78.6M
Call Options Held
304K
Put Options Held
142K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.81B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email